US OptionsDetailed Quotes
AYI250117P290000
- 0.19
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
0.00Open0.19Pre Close0 Volume37 Open Interest290.00Strike Price0.00Turnover2514.71%IV13.68%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type-0.0227Delta0.0025Gamma1767.05Leverage Ratio-215.8115Theta0.0000Rho-40.17Eff Leverage0.0005Vega
Acuity Brands Stock Discussion
Sign in to post a comment
Lithium: $Albemarle (ALB.US)$ $Sigma Lithium (SGML.US)$
LED: $OSRAM LICHT AG UNSP ADR EA REPR 0.333 ORD SHS (OSAGY.US)$ $Acuity Brands (AYI.US)$
Silicon: $Advanced Micro Devices (AMD.US)$ $Intel (INTC.US)$ $NVIDIA (NVDA.US)$ $Broadcom (AVGO.US)$ $Qualcomm (QCOM.US)$ $Applied Materials (AMAT.US)$
Platinum: $ANGLO AMERICAN PLATINUM LTD SPON ADR EACH REP 0.16667 ORD SHS (ANGPY.US)$ $IMPALA PLATINUM HLDGS SPON ADR 1 REP 1 ORD ZAR0.025 (IMPUY.US)$ $Sibanye Stillwater (SBSW.US)$
...
LED: $OSRAM LICHT AG UNSP ADR EA REPR 0.333 ORD SHS (OSAGY.US)$ $Acuity Brands (AYI.US)$
Silicon: $Advanced Micro Devices (AMD.US)$ $Intel (INTC.US)$ $NVIDIA (NVDA.US)$ $Broadcom (AVGO.US)$ $Qualcomm (QCOM.US)$ $Applied Materials (AMAT.US)$
Platinum: $ANGLO AMERICAN PLATINUM LTD SPON ADR EACH REP 0.16667 ORD SHS (ANGPY.US)$ $IMPALA PLATINUM HLDGS SPON ADR 1 REP 1 ORD ZAR0.025 (IMPUY.US)$ $Sibanye Stillwater (SBSW.US)$
...
13
1
2
AYI's stock is undervalued, with its future prospects not fully reflected in the current price. Consider financial health before investing.
The recent sale by Barry Goldman at around the present share price of US$225 raises some caution. While Acuity Brands is profitable and growing profits, the fact that insiders have been selling shares warrants careful consideration before buying.
1
Acuity Brands may face weaker earnings and a slower growth rate. Investors retaining their shares and potential new ones could end up paying a higher premium.
The company's share price increase, although significant, fell short of the market return. However, the yearly gain outperformed the average annual return over five years, suggesting a successfully pursued strategy that might be attracting new investors.
Acuity Brands' consistent returns suggest assurance for long-term investment despite not being particularly high. This has led to a 46% return for shareholders over the past five years, making the stock worth further investigation.
Despite its solid earnings outlook not yet fully reflected in the share price, Acuity Brands' stock may still offer buying opportunity. Nevertheless, additional considerations like financial health should be factored in the valuation.
The latest data on the U.S. labor market will be the investors' main focus this week, with implications for consumer spending and Federal Reserve policy.
There will also be a handful of notable earnings reports this week. On Tuesday, $McCormick & Co (MKC.US)$ releases quarterly result, followed by $Acuity Brands (AYI.US)$ on Wednesday. $Constellation Brands (STZ.US)$, and $Levi Strauss & Co. (LEVI.US)$ report on Thursday.
On Tuesd...
There will also be a handful of notable earnings reports this week. On Tuesday, $McCormick & Co (MKC.US)$ releases quarterly result, followed by $Acuity Brands (AYI.US)$ on Wednesday. $Constellation Brands (STZ.US)$, and $Levi Strauss & Co. (LEVI.US)$ report on Thursday.
On Tuesd...
+3
26
8
$AbbVie (ABBV.US)$ $Adicet Bio (ACET.US)$ $American Outdoor Brands (AOUT.US)$ $Acuity Brands (AYI.US)$ $Alibaba (BABA.US)$ $Beneficient (BENF.US)$ $Bristol-Myers Squibb (BMY.US)$ $Concentrix (CNXC.US)$ $Fangdd Network (DUO.US)$ $Kintara Therapeutics (KTRA.US)$ $Salesforce (CRM.US)$ $CorMedix (CRMD.US)$ $Minerva Neurosciences (NERV.US)$ $Novagold Resources (NG.US)$
3
No comment yet
TheOracleOfBroMaha : You should start an ETF with this! Great stuff